Ian Greenberg
AeroLeads people directory · profile

Ian Greenberg Email & Phone Number

VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio at GSK at GSK
Location: Greater Philadelphia, United States, United States 6 work roles 2 schools
3 work emails found @gsk.com 6 phones found area 410, 727, 443, and 212 LinkedIn matched
4 data sources Profile completeness 100%

Contact Signals · 3 work emails · 6 phones

Work email i****@gsk.com
Direct phone (410) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
GSK
Role
VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio at GSK
Location
Greater Philadelphia, United States, United States

Who is Ian Greenberg? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Ian Greenberg is listed as VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio at GSK at GSK, based in Greater Philadelphia, United States, United States. AeroLeads shows a work email signal at gsk.com, phone signal with area code 410, 727, 443, 212, and a matched LinkedIn profile for Ian Greenberg.

Ian Greenberg previously worked as VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio at Gsk and Executive Director - Corporate & Business Development at Gsk. Ian Greenberg holds Bs, Biochemistry from University Of Pittsburgh.

Company email context

Email format at GSK

This section adds company-level context without repeating Ian Greenberg's masked contact details.

{first}.{last}@gsk.com
92% confidence

AeroLeads found 3 current-domain work email signals for Ian Greenberg. Compare company email patterns before reaching out.

Profile bio

About Ian Greenberg

+16 years leading complex transactions by leveraging experience in drug discovery, commercial, & finance - buy side / sell side - Transactions / Search & Evaluation / Strategic PlanningSelected Business Development Transactions:- $2.0bn acquisition of Bellus - camlipixant (Ph3)- Scynexis license Ibrexa (Approved) upfront $90m- Spero license Tebi (Ph3) Upfront $66m & equity up to 19.9% - $1.9bn acquisition of Sierra Oncology - momelotinib (Ph3)- Acquisition of Tesaro $5b (commercial)- Divestment of Tapinarof $330m (Phase 3)- Alder Rheumatoid Arthritis License ALD518 (Phase 2) - Ensemble Research Collaboration- Adnexus Therapeutics Acquisition- Pfizer Apixaban Co-Development / Co-Commercialization- Adnexus Oncology Research Collaboration ('08 Allicense “Deal of the Year”)

Listed skills include Drug Discovery, Oncology, Clinical Trials, Assay Development, and 17 others.

Current workplace

Ian Greenberg's current company

Company context helps verify the profile and gives searchers a useful next step.

GSK
Gsk
VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio at GSK
AeroLeads page
6 roles · 31 years

Ian Greenberg work experience

A career timeline built from the work history available for this profile.

Vp & Head Of Business Development, Global Pharmaceuticals Commercial Portfolio

Current
Gsk

Brentford, Middlesex, GB

- $2.0bn acquisition of Bellus - camlipixant (Ph3)- Scynexis license Ibrexa (Approved) upfront $90m- Spero license Tebi (Ph3) Upfront $66m & equity up to 19.9% - $1.9bn acquisition of Sierra Oncology - momelotinib (Ph3)

Sep 2020 - Present

Executive Director - Corporate & Business Development

Gsk

Brentford, Middlesex, GB

Business & Corporate Development

Mar 2011 - Sep 2020

Director, Business Development

Lawrence Township, NJ, US

Lead negotiator for the Adnexus Oncology Partnership which won 2008 Allicense “Deal of the Year”

Oct 2005 - Mar 2011

Associate Director Finance, Business Development

Lawrence Township, NJ, US

Support Corporate and Business Development in assessing the commercial attractiveness and economic feasibility of opportunities.

Apr 2000 - Nov 2005

Diabetes Pharmaceutical Sales

Indianapolis, Indiana, US

Successfully launched Actos, promoted an insulin delivery device and Prozac. Recognized as a top performer with a monthly ranking as high as 3 out of 510 representatives in the country and was consistently in the top 10%.

Apr 1998 - Apr 2000

Biochemist - Oncology Drug Discovery

Rahway, New Jersey, US

Responsible for primary high throughput screening, enzyme purification and enzyme kinetics of Farnesyl Protein Transferase. Instrumental in establishing a pharmacokinetic / pharmacodynamic assay by LC/MS.

1995 - 1998 ~3 yrs
2 education records

Ian Greenberg education

Bs, Biochemistry

University Of Pittsburgh

Mba, Finance

Drexel University
FAQ

Frequently asked questions about Ian Greenberg

Quick answers generated from the profile data available on this page.

What company does Ian Greenberg work for?

Ian Greenberg works for GSK.

What is Ian Greenberg's role at GSK?

Ian Greenberg is listed as VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio at GSK at GSK.

What is Ian Greenberg's email address?

AeroLeads has found 3 work email signals at @gsk.com for Ian Greenberg at GSK.

What is Ian Greenberg's phone number?

AeroLeads has found 6 phone signal(s) with area code 410, 727, 443, 212 for Ian Greenberg at GSK.

Where is Ian Greenberg based?

Ian Greenberg is based in Greater Philadelphia, United States, United States while working with GSK.

What companies has Ian Greenberg worked for?

Ian Greenberg has worked for Gsk, Bristol-Myers Squibb, Eli Lilly, and Merck.

How can I contact Ian Greenberg?

You can use AeroLeads to view verified contact signals for Ian Greenberg at GSK, including work email, phone, and LinkedIn data when available.

What schools did Ian Greenberg attend?

Ian Greenberg holds Bs, Biochemistry from University Of Pittsburgh.

What skills is Ian Greenberg known for?

Ian Greenberg is listed with skills including Drug Discovery, Oncology, Clinical Trials, Assay Development, Mergers And Acquisitions, Diabetes, Market Research, and Pharmaceutical Sales.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.